Which has stronger valuation & earnings, NSPR or GUTS?

InspireMD has higher revenue and earnings than Fractyl Health. InspireMD is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.85M 3.11 -$19.92M -$0.73 N/A Fractyl Health $90K 1,207.50 -$140.95M -$1.29 N/A

Is NSPR or GUTS more profitable?

Fractyl Health has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Fractyl Health N/A -4,053.15% -96.41%

Does the media prefer NSPR or GUTS?

In the previous week, InspireMD and InspireMD both had 3 articles in the media. InspireMD's average media sentiment score of 0.25 beat Fractyl Health's score of -0.05 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fractyl Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is STIM or NSPR more profitable?

Neuronetics has a net margin of -24.48% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -24.48% -139.83% -27.13% InspireMD -413.96% -69.42% -57.68%

Does the media favor STIM or NSPR?

In the previous week, InspireMD had 1 more articles in the media than Neuronetics. MarketBeat recorded 3 mentions for InspireMD and 2 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.71 beat InspireMD's score of 0.25 indicating that Neuronetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer NSPR or MBOT?

In the previous week, InspireMD and InspireMD both had 3 articles in the media. InspireMD's average media sentiment score of 0.25 beat Microbot Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is VANI or NSPR more profitable?

Vivani Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Vivani Medical's return on equity. Company Net Margins Return on Equity Return on Assets Vivani Medical N/A -264.04% -79.85% InspireMD -413.96% -69.42% -57.68%

Does the media prefer NSPR or LAKE?

In the previous week, InspireMD had 1 more articles in the media than Lakeland Industries. MarketBeat recorded 3 mentions for InspireMD and 2 mentions for Lakeland Industries. Lakeland Industries' average media sentiment score of 1.46 beat InspireMD's score of 0.25 indicating that Lakeland Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lakeland Industries 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InspireMD (NSPR) Competitors

$0.72 +0.04 (+5.71%)

Closing price 04:00 PM Eastern

Extended Trading

$0.69 -0.03 (-3.88%)

As of 04:41 PM Eastern

Compare

NSPR vs. GUTS, STIM, MBOT, VANI, and LAKE

Should you buy InspireMD stock or one of its competitors? MarketBeat compares InspireMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with InspireMD include Fractyl Health (GUTS), Neuronetics (STIM), Microbot Medical (MBOT), Vivani Medical (VANI), and Lakeland Industries (LAKE).

How does InspireMD compare to Fractyl Health?

InspireMD (NYSE:NSPR) and Fractyl Health (NASDAQ:GUTS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

Fractyl Health has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Fractyl Health	N/A	-4,053.15%	-96.41%

InspireMD has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.32, suggesting that its share price is 132% more volatile than the broader market.

44.8% of InspireMD shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 8.5% of Fractyl Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, InspireMD and InspireMD both had 3 articles in the media. InspireMD's average media sentiment score of 0.25 beat Fractyl Health's score of -0.05 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fractyl Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD has higher revenue and earnings than Fractyl Health. InspireMD is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.11	-$19.92M	-$0.73	N/A
Fractyl Health	$90K	1,207.50	-$140.95M	-$1.29	N/A

InspireMD presently has a consensus price target of $4.50, suggesting a potential upside of 525.09%. Fractyl Health has a consensus price target of $5.12, suggesting a potential upside of 647.45%. Given Fractyl Health's higher probable upside, analysts plainly believe Fractyl Health is more favorable than InspireMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

InspireMD beats Fractyl Health on 9 of the 15 factors compared between the two stocks.

How does InspireMD compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Neuronetics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

In the previous week, InspireMD had 1 more articles in the media than Neuronetics. MarketBeat recorded 3 mentions for InspireMD and 2 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.71 beat InspireMD's score of 0.25 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InspireMD has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.07	-$39M	-$0.54	N/A
InspireMD	$10.85M	3.11	-$19.92M	-$0.73	N/A

Neuronetics has a net margin of -24.48% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-24.48%	-139.83%	-27.13%
InspireMD	-413.96%	-69.42%	-57.68%

Neuronetics currently has a consensus target price of $4.00, suggesting a potential upside of 73.91%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 525.09%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

InspireMD beats Neuronetics on 8 of the 15 factors compared between the two stocks.

How does InspireMD compare to Microbot Medical?

InspireMD (NYSE:NSPR) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

InspireMD currently has a consensus target price of $4.50, indicating a potential upside of 525.09%. Microbot Medical has a consensus target price of $6.63, indicating a potential upside of 264.01%. Given InspireMD's higher probable upside, equities research analysts clearly believe InspireMD is more favorable than Microbot Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

InspireMD has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

Microbot Medical has lower revenue, but higher earnings than InspireMD. Microbot Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.11	-$19.92M	-$0.73	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Microbot Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Microbot Medical's return on equity of -21.84% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Microbot Medical	N/A	-21.84%	-20.71%

In the previous week, InspireMD and InspireMD both had 3 articles in the media. InspireMD's average media sentiment score of 0.25 beat Microbot Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 34.1% of InspireMD shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

InspireMD and Microbot Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does InspireMD compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Vivani Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
InspireMD	-413.96%	-69.42%	-57.68%

Vivani Medical currently has a consensus target price of $3.75, suggesting a potential upside of 167.86%. InspireMD has a consensus target price of $4.50, suggesting a potential upside of 525.09%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Vivani Medical has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

In the previous week, InspireMD had 3 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for InspireMD and 0 mentions for Vivani Medical. InspireMD's average media sentiment score of 0.25 beat Vivani Medical's score of 0.00 indicating that InspireMD is being referred to more favorably in the news media.

Company	Overall Sentiment
Vivani Medical	Neutral
InspireMD	Neutral

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InspireMD has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
InspireMD	$10.85M	3.11	-$19.92M	-$0.73	N/A

Summary

InspireMD beats Vivani Medical on 11 of the 15 factors compared between the two stocks.

How does InspireMD compare to Lakeland Industries?

InspireMD (NYSE:NSPR) and Lakeland Industries (NASDAQ:LAKE) are related small-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Lakeland Industries has a net margin of -10.87% compared to InspireMD's net margin of -413.96%. Lakeland Industries' return on equity of -6.64% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Lakeland Industries	-10.87%	-6.64%	-4.13%

InspireMD has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Lakeland Industries has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market.

InspireMD has higher earnings, but lower revenue than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	3.11	-$19.92M	-$0.73	N/A
Lakeland Industries	$193.32M	0.62	-$25.31M	-$2.13	N/A

In the previous week, InspireMD had 1 more articles in the media than Lakeland Industries. MarketBeat recorded 3 mentions for InspireMD and 2 mentions for Lakeland Industries. Lakeland Industries' average media sentiment score of 1.46 beat InspireMD's score of 0.25 indicating that Lakeland Industries is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lakeland Industries	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

44.8% of InspireMD shares are held by institutional investors. Comparatively, 71.7% of Lakeland Industries shares are held by institutional investors. 34.1% of InspireMD shares are held by company insiders. Comparatively, 3.4% of Lakeland Industries shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 525.09%. Lakeland Industries has a consensus target price of $16.00, suggesting a potential upside of 32.78%. Given InspireMD's stronger consensus rating and higher possible upside, equities research analysts plainly believe InspireMD is more favorable than Lakeland Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Lakeland Industries	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

InspireMD beats Lakeland Industries on 8 of the 15 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$33.72M	$5.69B	$6.80B	$24.05B
Dividend Yield	N/A	1.78%	2.60%	4.21%
P/E Ratio	-0.96	23.58	279.73	32.26
Price / Sales	3.11	59.01	649.61	15.16
Price / Cash	N/A	32.53	28.64	18.72
Price / Book	0.39	6.53	11.12	4.90
Net Income	-$19.92M	$150.91M	$3.48B	$1.07B
7 Day Performance	5.17%	6.54%	2.67%	1.60%
1 Month Performance	2.99%	1.22%	-2.70%	1.75%
1 Year Performance	-73.04%	10.21%	64.43%	20.44%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NSPR InspireMD	3.8227 of 5 stars	$0.72 +5.7%	$4.50 +525.1%	-74.7%	$33.72M	$10.85M	N/A	50
GUTS Fractyl Health	3.6643 of 5 stars	$0.72 -9.8%	$5.12 +608.6%	-62.6%	$127.08M	$90K	N/A	102	News Coverage Upcoming Earnings Gap Up
STIM Neuronetics	3.362 of 5 stars	$1.87 +3.3%	$4.00 +113.9%	-51.1%	$125.95M	$149.16M	N/A	180	Upcoming Earnings Gap Down
MBOT Microbot Medical	1.7857 of 5 stars	$1.68 -3.4%	$6.63 +294.3%	-30.6%	$116.87M	N/A	N/A	20	News Coverage Positive News Upcoming Earnings
VANI Vivani Medical	3.5504 of 5 stars	$1.31 +0.8%	$3.75 +186.3%	+0.0%	$112.11M	N/A	N/A	20	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors

NSPR vs. GUTS, STIM, MBOT, VANI, and LAKE

How does InspireMD compare to Fractyl Health?

Summary

How does InspireMD compare to Neuronetics?

Summary

How does InspireMD compare to Microbot Medical?

Summary

How does InspireMD compare to Vivani Medical?

Summary

How does InspireMD compare to Lakeland Industries?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InspireMD (NSPR) Competitors

NSPR vs. GUTS, STIM, MBOT, VANI, and LAKE

How does InspireMD compare to Fractyl Health?

Is NSPR or GUTS more profitable?

Which has more volatility & risk, NSPR or GUTS?

Do institutionals & insiders hold more shares of NSPR or GUTS?

Does the media prefer NSPR or GUTS?

Which has stronger valuation & earnings, NSPR or GUTS?

Do analysts rate NSPR or GUTS?

Summary

How does InspireMD compare to Neuronetics?

Do insiders & institutionals hold more shares of STIM or NSPR?

Which has more volatility and risk, STIM or NSPR?

Does the media favor STIM or NSPR?

Which has better valuation and earnings, STIM or NSPR?

Is STIM or NSPR more profitable?

Do analysts prefer STIM or NSPR?

Summary

How does InspireMD compare to Microbot Medical?

Do analysts rate NSPR or MBOT?

Which has more risk and volatility, NSPR or MBOT?

Which has better earnings and valuation, NSPR or MBOT?

Is NSPR or MBOT more profitable?

Does the media prefer NSPR or MBOT?

Do institutionals & insiders believe in NSPR or MBOT?

Summary

How does InspireMD compare to Vivani Medical?

Is VANI or NSPR more profitable?

Do analysts recommend VANI or NSPR?

Which has more risk & volatility, VANI or NSPR?

Does the media favor VANI or NSPR?

Do institutionals & insiders hold more shares of VANI or NSPR?

Which has higher valuation and earnings, VANI or NSPR?

Summary

How does InspireMD compare to Lakeland Industries?

Is NSPR or LAKE more profitable?

Which has more volatility and risk, NSPR or LAKE?

Which has higher earnings and valuation, NSPR or LAKE?

Does the media prefer NSPR or LAKE?

Do insiders and institutionals believe in NSPR or LAKE?

Do analysts recommend NSPR or LAKE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools